Smoking cessation interventions for patients with severe mental illnesses a review of clinical effectiveness and guidelines
Treatment may be able to lessen the significant burden and associated risks of smoking among people with mental illness, but concerns about effectiveness and safety may limit its potential. To inform decisions about using pharmacotherapy among those with mental illness, specific evidence is thus req...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, August 24, 2017
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Treatment may be able to lessen the significant burden and associated risks of smoking among people with mental illness, but concerns about effectiveness and safety may limit its potential. To inform decisions about using pharmacotherapy among those with mental illness, specific evidence is thus required. As such, this rapid review summarizes the evidence on the effectiveness and evidence-based guidelines on smoking cessation intervention among those with severe mental illness |
|---|---|
| Physical Description: | 1 PDF file (45 pages) illustrations |